{"id":1445,"createDateTime":"2026-11-17T03:05:41.937Z","archiveDateTime":"2027-12-31T00:00:00.000Z","name":"Adherence, monitoring and treatment failure","image":"42c6101fc6b109852056a409e1fed6c3f0822709743a40eb83dfd3c2","imageThumbnail":"9a2595f379105483f145c46085707f6720a1d5d0551ede0bb34f94f9","about":"What should you ask when a patient says their iron tablets are upsetting their stomach? GP Dr Sneha explains how to adjust the dose or timing without slowing the replenishment of iron stores, how to check adherence and ongoing blood loss, and when a poor ferritin response should prompt further investigation or IV iron. \n\nThis activity comprises a short educational video, followed by a reflective activity. Participants must complete both components to qualify for 30 minutes of Reviewing Performance (RP) Hours. \n\n# Learning Outcomes\n1. Outline the findings of a trial comparing oral iron formulations and their effect on ferritin.\n2. Critically reflect on recent patient interactions to inform oral iron choice.\n3. Apply the trial findings to select oral iron based on expected repletion and tolerability.\n\n# Provider\nThe Provider of this activity is [Praxhub](https://app.praxhub.com/orgs/1). Praxhub is an accredited Major Provider under the RACGP CPD Program. For any questions regarding this activity please contact support@praxhub.com.","type":"video","summaryViewCount":14,"startDateTime":null,"durationSecs":352,"endDateTime":null,"organisation":{"id":101,"name":"Arrotex","logoImage":"343d2282723763f021df947917df828894bcf90cd0942a7b794bdcd8","logoImageThumbnail":"4cb9c205c6d9ce99135b8445d977a6b5da5a4f07cbd1b9811fbd93f2","industry":"Pharmaceutical"},"provider":{"id":1,"name":"Praxhub","logoImage":"7d8c82e84cfeb7556fa842c1980c93b8144ab0959b0630c17e557baf","logoImageThumbnail":"78ba1e568155afb45aa67fc6f7337c076b0a1aa9182ceb80ac9b1095","industry":"Health Technology"},"commentCount":0,"likeCount":0,"associations":["RACGP"],"rewards":["Reviewing Performance • 0.5 hours"],"rewardImages":[{"image":"5d64f0d6ae84ff1cde65cfd2894173e396aba166d91def6443888242","aspectRatio":2.396}],"presenters":[{"id":18322,"specialty":{"id":94,"name":"General Practice"},"name":"Sneha Wadhwani","title":null,"profileImage":"7695ec0028b2766d11eaa01c092d62cef40ff704b6f24372ee5096c0","profileImageThumbnail":"c651de82a2712a508a452b847afe2f8cb3c8a4cd5a04f7d0ab395d7d"}],"relatedEducation":[{"id":1447,"name":"Low ferritin, normal haemoglobin ","image":"f892f5d709d4c9795da1d4c0d98a5fef5844d98d80c3817ed61f2a0f","imageThumbnail":"7197b75ed4e9220df548f073c675338b74d608ede3f5e9601a27d03c","type":"video","startDateTime":null,"durationSecs":375,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1446,"name":"Balancing repletion, tolerability and patient fit ","image":"069c365b1d1c703cb0067d18ad632660f3c10a98b7e4877dc022418d","imageThumbnail":"c6f7e04d9fad4e4fc5f49167a567b311a71ea527eb084db09d66beb1","type":"video","startDateTime":null,"durationSecs":326,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1441,"name":"What does the McKay study show about oral iron formulation?","image":"81ca5de7c17d1dd41185a9696714ed678ed88cbfd01d72244c358c5f","imageThumbnail":"798f8bbaef4634a9c69c2a37693664f2eecf4d103c7c76e5d5069569","type":"video","startDateTime":null,"durationSecs":247,"associationEducationTypes":[],"organisation":{"id":101,"name":"Arrotex"}},{"id":1405,"name":"Hormonal Acne Management for General Practice","image":"c6507a6d4a2eaa2b0fbec06d1572d229893ec9fbf6aabb7afa540d8f","imageThumbnail":"bb0b3a191abc66b9631de005b87931e2765d514fc7d71ae5d2fd8f57","type":"video","startDateTime":null,"durationSecs":5735,"associationEducationTypes":["EA","MO","RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1396,"name":"Acne in Gender-Affirming Care","image":"5cfdbc6378b39637620ca942ec44b9501852d3e94d156d2b1a2fb47f","imageThumbnail":"f7bf04fa60267c97cf09221a427e1d9577f2c49f4f19b6ea16dffc2e","type":"video","startDateTime":null,"durationSecs":398,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}},{"id":1388,"name":"The GP's role in second line therapy for Endometriosis","image":"d14cda1b05a5e3f26aba936158372444bfb03ee082bc1034f58a2d3c","imageThumbnail":"b80c45f17a4a4bf9271030173e8e84d94d8cd800849649bc987c1444","type":"video","startDateTime":null,"durationSecs":727,"associationEducationTypes":["RP"],"organisation":{"id":101,"name":"Arrotex"}}]}